CSL LIMITED (CSL) operates in the Pharmaceuticals Biotechnology & Life Sciences industry category. CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally
The most recent ex-dividend date was 11-03-2020. This dividend was $1.471271 and was not franked. and was partially franked at 0%. The date paid for this dividend is 09-04-2020.